1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Upsurge in the therapeutic discovery ventures
4.1.2 Highly robust and populated pipeline for novel drugs
4.1.3 Increase in healthcare expenditure
4.2 Restraints
4.2.1 Market shift from branded to generic drugs
4.2.2 Stringent regulations for drug discovery
4.3 Opportunities
4.3.1 Growing focus on developing drugs for new ROA
4.3.2 Approvals for new drugs
4.4 Challenges
4.4.1 Side effects coupled with product recalls
5. North America Drug Discovery Market - By Technology
5.1 Protein and Nucleic acid isolation
5.2 Chromatography
5.3 Gel Electrophoresis
5.4 Mass Spectrometry
5.5 High Throughput Screening
5.6 Protein Microarrays
5.7 DNA Microarrays
5.8 QPCR
5.9 Others
6. North America Drug Discovery Market- By Service
6.1 Biological Services
6.2 Chemical Services
6.3 Pharmaceutical Services
6.4 Drug Metabolism and Pharmacokinetics (DMPK) Services
7. North America Drug Discovery Market-By End Users
7.1 Biopharmaceuticals
7.2 Biotech companies
7.3 Pharmaceutical companies
7.4 Research Institutes
7.5 Others
8. North America Drug Discovery Market - By Country
8.1. Introduction
8.2. USA
8.3. Canada
8.4. Mexico
9. Company Profiles
9.1 Roche Holding AG
9.2 Merck & Co. Inc.
9.3 Eli Lily
9.4 GlaxoSmithKline LLC
9.5 Pfizer, Inc.
9.6 AstraZeneca PLC
9.7 Johnson and Johnson
9.8 Sanofi
9.9 Jubilant Biosys
9.10 Bayer AG
9.11 Covance
9.12 Boehringer Ingelheim GmBh
9.13 Albany Molecular Research Inc.
9.14 Charles River Laboratories
9.15 Infosys
10. North America Drug Discovery Market - Competitive Landscape
10.1 Market Share Analysis
10.2 Strategies Adopted by top companies
10.3 Mergers, Acquisitions, Collaborations & Agreements
11. Market Insights
11.1 Insights of Industry Experts
11.2 Investment Opportunities
11.3 Analyst Opinion
12. Appendix
12.1 List of Tables
12.2 List of Figures
